Curaleaf Holdings Future Growth
Future criteria checks 4/6
Curaleaf Holdings is forecast to grow earnings and revenue by 65.6% and 10.7% per annum respectively. EPS is expected to grow by 61.1% per annum. Return on equity is forecast to be 17.1% in 3 years.
Key information
65.6%
Earnings growth rate
61.1%
EPS growth rate
| Pharmaceuticals earnings growth | 69.7% |
| Revenue growth rate | 10.7% |
| Future return on equity | 17.1% |
| Analyst coverage | Good |
| Last updated | 10 May 2024 |
Recent future growth updates
Recent updates
Subdued Growth No Barrier To Curaleaf Holdings, Inc. (TSE:CURA) With Shares Advancing 25%
Jan 19
Does Curaleaf Holdings (CSE:CURA) Have A Healthy Balance Sheet?
Dec 11Is Curaleaf Holdings (CSE:CURA) Using Too Much Debt?
Sep 08Curaleaf Holdings (CSE:CURA) Has Debt But No Earnings; Should You Worry?
May 28We Think Curaleaf Holdings (CSE:CURA) Is Taking Some Risk With Its Debt
Sep 05Here's Why Curaleaf Holdings (CSE:CURA) Has A Meaningful Debt Burden
May 20Is Curaleaf Holdings (CSE:CURA) A Risky Investment?
Oct 26Loss-Making Curaleaf Holdings, Inc. (CSE:CURA) Set To Breakeven
Mar 20Is Curaleaf Holdings' (CSE:CURA) Share Price Gain Of 188% Well Earned?
Feb 27Calculating The Fair Value Of Curaleaf Holdings, Inc. (CSE:CURA)
Feb 01Curaleaf Holdings (CSE:CURA) Has A Somewhat Strained Balance Sheet
Jan 11
What Kind Of Investors Own Most Of Curaleaf Holdings, Inc. (CSE:CURA)?
Dec 24Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,684 | 195 | 199 | 398 | 3 |
| 12/31/2025 | 1,546 | 4 | 151 | 173 | 12 |
| 12/31/2024 | 1,409 | -80 | 58 | 120 | 12 |
| 3/31/2024 | 1,353 | -237 | 46 | 111 | N/A |
| 12/31/2023 | 1,347 | -230 | 5 | 75 | N/A |
| 9/30/2023 | 1,402 | -457 | 1 | 85 | N/A |
| 6/30/2023 | 1,395 | -426 | -27 | 84 | N/A |
| 3/31/2023 | 1,377 | -382 | -127 | 15 | N/A |
| 12/31/2022 | 1,275 | -258 | -88 | 46 | N/A |
| 9/30/2022 | 1,244 | -157 | -137 | 22 | N/A |
| 6/30/2022 | 1,234 | -202 | -150 | 11 | N/A |
| 3/31/2022 | 1,232 | -223 | -170 | -7 | N/A |
| 12/31/2021 | 1,196 | -206 | -230 | -58 | N/A |
| 9/30/2021 | 1,118 | -164 | -201 | -27 | N/A |
| 6/30/2021 | 984 | -90 | -237 | -89 | N/A |
| 3/31/2021 | 790 | -57 | -127 | 8 | N/A |
| 12/31/2020 | 627 | -57 | -114 | 12 | N/A |
| 9/30/2020 | 472 | -52 | -110 | -25 | N/A |
| 6/30/2020 | 351 | -50 | -86 | 5 | N/A |
| 3/31/2020 | 282 | -72 | -110 | -23 | N/A |
| 12/31/2019 | 221 | -67 | -120 | -38 | N/A |
| 9/30/2019 | 178 | -57 | -124 | -37 | N/A |
| 6/30/2019 | 137 | -84 | -121 | -50 | N/A |
| 3/31/2019 | 103 | -64 | -101 | -45 | N/A |
| 12/31/2018 | 77 | -56 | -78 | -33 | N/A |
| 9/30/2018 | 51 | -40 | -49 | -20 | N/A |
| 6/30/2018 | 36 | -6 | -33 | -10 | N/A |
| 3/31/2018 | 25 | -3 | -25 | -10 | N/A |
| 12/31/2017 | 19 | -3 | N/A | -8 | N/A |
| 12/31/2016 | 4 | 0 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CURA is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.1%).
Earnings vs Market: CURA is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: CURA is expected to become profitable in the next 3 years.
Revenue vs Market: CURA's revenue (10.7% per year) is forecast to grow faster than the Canadian market (6.6% per year).
High Growth Revenue: CURA's revenue (10.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CURA's Return on Equity is forecast to be low in 3 years time (17.1%).